Full text
PDFPage 1253

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BURRELL C. D. Fatal marrow aplasia after treatment with carbimazole. Br Med J. 1956 Jun 23;1(4981):1456–1457. doi: 10.1136/bmj.1.4981.1456. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen B., Lang R., Jutrin Y., Ravid M. Recurrent agranulocytosis induced by two different antithyroid agents. Med J Aust. 1983 Jul 9;2(1):38–39. doi: 10.5694/j.1326-5377.1983.tb142086.x. [DOI] [PubMed] [Google Scholar]
- Cooper D. S. Antithyroid drugs. N Engl J Med. 1984 Nov 22;311(21):1353–1362. doi: 10.1056/NEJM198411223112106. [DOI] [PubMed] [Google Scholar]
- FRASER T. R., GARROD O., HANNO M. G., JADRESIC A. Antithyroid activity and toxicity of mercazole and neo-mercazole. J Clin Endocrinol Metab. 1954 Oct;14(10):1230–1244. doi: 10.1210/jcem-14-10-1230. [DOI] [PubMed] [Google Scholar]
- Farbman K., Wheeler M. F., Glick S. M. Arthritis induced by antithyroid medication. N Y State J Med. 1969 Mar 15;69(6):826–831. [PubMed] [Google Scholar]
- Hung W., August G. P. A "collagen-like" syndrome associated with antithyroid therapy. J Pediatr. 1973 May;82(5):852–854. doi: 10.1016/s0022-3476(73)80081-2. [DOI] [PubMed] [Google Scholar]
- MARTINEZ-LOPEZ J. I., GREENBERG S. E., KLING R. R. Drug-induced hepatic injury during methimazole therapy. Gastroenterology. 1962 Jul;43:84–87. [PubMed] [Google Scholar]
- Wall J. R., Fang S. L., Kuroki T., Ingbar S. H., Braverman L. E. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis. J Clin Endocrinol Metab. 1984 May;58(5):868–872. doi: 10.1210/jcem-58-5-868. [DOI] [PubMed] [Google Scholar]
